Skip to main content

J. Silvio Gutkind, Ph.D. Receives American Cancer Society (ACS) Research Professor Award

silvio-gutkind.jpg SAN DIEGO, November 13, 2023 –  The nation’s largest non-government, non-profit funder of cancer researcher, ACS, has awarded Moores Member, J. Silvio Gutkind, Ph.D., the ACS Research Professor Award. Dr. Gutkind is one of two recipients of this prestigious award for investigators who have made ground-breaking contributions in cancer research. This award recognizes exceptional track records in leadership, service, and mentoring in cancer research. 

The ACS Extramural Discovery Science program will fund investigators at 72 institutions across the United States starting in 2024, who include Dr. Gutkind and his research program for Multimodal Precision Cancer Targeted and Immunotherapies. His program will develop novel multimodal precision therapies and immunotherapies for the treatment of cancer. His proposed strategic plan will address the limitations of current targeted therapies and immunotherapies by exploring combinatorial approaches and identifying resistance mechanisms.

“I am thrilled to be named ACS Research Professor,” expressed Dr. Gutkind. “I’m so grateful to the ACS for this honor and for recognizing our team’s efforts to prevent and treat cancer. I’m looking forward to delivering our discoveries to all patients and communities.”

The most notable recognition by the ACS, the ACS Research Professor Award seeks to improve the lives of cancer patients, families, and caregivers through research, patient services, and advocacy. In addition, to maximize impact, ACS has established six priority research areas to advance its mission to reduce the cancer burden in the United States. Learn More

About Moores Cancer Center

Established in 1978, the UC San Diego, Moores Cancer Center is not only one of just 53 National Cancer Institute (NCI) designated Comprehensive Cancer Centers in the United States, but also the only one operating in the San Diego region. Moores Cancer Center delivers discoveries from the laboratories of UC San Diego, La Jolla Institute for Immunology, and San Diego State University, through the highly ranked cancer services of UC San Diego Health. Studies show that outcomes are better at NCI-designated Comprehensive Cancer Centers. Indeed, the cancer services of UC San Diego Health have been ranked #1 in San Diego, with 10 specialties ranking nationally, by U.S. News & World Report, as reported in its 2022–2023 "Best Hospitals" survey.  

About the American Cancer Society

The American Cancer Society is a leading cancer-fighting organization with a vision to end cancer as we know it, for everyone. For more than 100 years, we have been improving the lives of people with cancer and their families as the only organization combating cancer through advocacy, research, and patient support. We are committed to ensuring everyone has an opportunity to prevent, detect, treat, and survive cancer.